Breast Biopsy Devices Market Growth Analysis, and Forecast To 2022 – by Credence Research
The latest market report published by Credence Research
“Global Breast Biopsy Devices Market -
Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 - 2022,”
the breast biopsy devices market was valued at USD 617.62 Mn in 2015, and is
expected to reach USD 1,250.71 Mn by 2022, expanding at a CAGR of 10.6% from
2016 to 2022.
Browse the full report Breast Biopsy Devices Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022 at http://www.credenceresearch.com/report/breast-biopsy-devices-market
Browse the full report Breast Biopsy Devices Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022 at http://www.credenceresearch.com/report/breast-biopsy-devices-market
Market Insights
Breast cancer is among the most commonly diagnosed non-skin cancer across the world, with among the highest annual mortality. While the incidence of the disease is increasing at alarming rates in the developing markets, the breast cancer survival prognosis is reported to be con tenuously improving this proving development in the trends of early disease diagnosis and treatment outcomes. Pathological detection of breast cancer has evolved a long way until present with biopsy becoming the standard route of disease detection. With the introduction of minimally invasive biopsy procedures, intimating with fine needle aspiration, the global breast biopsy devices market has witnessed phenomenal growth over the period. Rapidly aging population and the proven correlation of age with the incidence of breast cancer is among the biggest contributors to the breast biopsy devices market. Alarming disease incidence and technological development resulting in rapid adoption of breast biopsy devices and related solutions are observed to be the major market drivers in the developing regions of the world. Introduction of guidance enabled biopsy systems has further facilitated the market development and assisted in containment of breast cancer incidence.
Breast cancer is among the most commonly diagnosed non-skin cancer across the world, with among the highest annual mortality. While the incidence of the disease is increasing at alarming rates in the developing markets, the breast cancer survival prognosis is reported to be con tenuously improving this proving development in the trends of early disease diagnosis and treatment outcomes. Pathological detection of breast cancer has evolved a long way until present with biopsy becoming the standard route of disease detection. With the introduction of minimally invasive biopsy procedures, intimating with fine needle aspiration, the global breast biopsy devices market has witnessed phenomenal growth over the period. Rapidly aging population and the proven correlation of age with the incidence of breast cancer is among the biggest contributors to the breast biopsy devices market. Alarming disease incidence and technological development resulting in rapid adoption of breast biopsy devices and related solutions are observed to be the major market drivers in the developing regions of the world. Introduction of guidance enabled biopsy systems has further facilitated the market development and assisted in containment of breast cancer incidence.
Market Competition Assessment
Te global breast biopsy devices
market is consolidated with a few players dominating the major chunk of the
market revenue. Players such as Hologic, Mammotome, C.R. Bar, Inc. are
identified and recognized as the global market leaders. Other players such as
Argon Medical Devices, Becton Dickinson and Company, Sterylab are the promising
market players with their established positions in prime market segments.
Key Market Movements
·
Increased preference for minimally
invasive biopsies
·
Rapid shift towards guided biopsies
·
Growth in adoption of disposable
consumables
·
· Request
Free Sample - http://www.credenceresearch.com/sample-request/57742
· About
Us:
Credence
Research is a worldwide market research and counseling firm that serves driving
organizations, governments, non-legislative associations, and not-for-benefits.
We offer our customers some assistance with making enduring enhancements to
their execution and understand their most imperative objectives. Over almost a
century, we’ve manufactured a firm extraordinarily prepared to this task.
Who we
are
Credence
Research is a worldwide firm, containing more than 15 research consultants and
almost 100 research and information professionals.
Our
customers mirror our worldwide nature. Around 45% are in Europe, 30% in the
Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.
Our firm
is intended to work as one. We are a solitary global research organization
united by a solid arrangement of qualities, concentrated on customer effect.
What we
do
We serve
customers at each level of their organization, in whatever limit we can be most
helpful, whether as a trusted counsel to top management or as a hands-on mentor
for forefront representatives. For each engagement, we collect a group with the
most suitable experience and ability.
No matter
the challenge, we concentrate on delivering functional and persevering results,
and preparing our customers to develop and lead. We join forces with customers
to place suggestions into practice. Our research specialist work
straightforwardly with customers over long stretches to create workforce
aptitudes, drive operational change, and apply new working strategies.
Contact:
Name: Chris
Smith
Designation: Global
Sales Manager
Ph: +1-800-361-8290
Post a Comment